Andryk Logan M, Neilson John C, Wooldridge Adam N, Hackbarth Donald A, Bedi Meena, Baynes Keith E, LoGiudice John A, Slusarczyk Sonia M, King David M
Department of Orthopaedic Surgery, Medical College of Wisconsin, Milwaukee, WI, United States.
Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.
Front Oncol. 2024 Jan 31;14:1250069. doi: 10.3389/fonc.2024.1250069. eCollection 2024.
Seroma development is a known complication following extremity and trunk soft-tissue sarcoma (STS) resection. The purpose of this study is to evaluate and characterize seroma outcomes and the development of associated complications.
A retrospective review of 123 patients who developed postoperative seromas following STS resection at a single institution was performed. Various patient and surgical factors were analyzed to determine their effect on overall seroma outcomes.
77/123 seromas (62.6%) were uncomplicated, 30/123 (24.4%) developed infection, and 16/123 (13.0%) were symptomatic and required aspiration or drainage for symptom relief at an average of 12.2 months postoperatively. 65/123 (52.8%) seromas resolved spontaneously at an average time of 12.41 months. Seromas in the lower extremity (p=0.028), surgical resection volume >864 cm3, (p=<0.001) and initial seroma volume >42 cm3 (p=<0.001) increased the likelihood of infection. 90% of infected seromas developed the infection within the first three months following initial resection. No seromas which were aspirated or drained ultimately developed an infection following these procedures, though 50% recurred.
Most seromas following STS resection are uncomplicated and do not require intervention, though a large resection cavity >864 cm3 and a large seroma volume >42 cm3 are risk factors for complications.
血清肿形成是四肢和躯干软组织肉瘤(STS)切除术后已知的并发症。本研究的目的是评估和描述血清肿的转归以及相关并发症的发生情况。
对在单一机构接受STS切除术后发生术后血清肿的123例患者进行回顾性分析。分析了各种患者和手术因素,以确定它们对总体血清肿转归的影响。
123例血清肿中,77例(62.6%)无并发症,30例(24.4%)发生感染,16例(13.0%)有症状,平均在术后12.2个月需要穿刺或引流以缓解症状。123例血清肿中,65例(52.8%)平均在12.41个月时自发消退。下肢血清肿(p=0.028)、手术切除体积>864 cm3(p<0.001)和初始血清肿体积>42 cm3(p<0.001)增加了感染的可能性。90%的感染性血清肿在初次切除后的前三个月内发生感染。尽管50%复发,但经穿刺或引流的血清肿在这些操作后最终均未发生感染。
STS切除术后的大多数血清肿无并发症,无需干预,尽管切除腔>864 cm3和血清肿体积>42 cm3是并发症的危险因素。